Identification of a locus modulating serum C-reactive protein levels on chromosome 5p15

Atherosclerosis

Volumn 196, Issue 2, 2008, Pages 863-870

  Keenan, Hillary A ^a,b   Poznik, G David ^a   Varo, Nerea ^c   Schneider, Jennifer ^d   Almasy, Laura ^d   Warram, James H ^a   Duggirala, Ravindranath ^d   Schoenbeck, Uwe ^e   Krolewski, Andrzej S ^a,b   Doria, Alessandro ^a,b  

^a JOSLIN DIABETES CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NAVARRA   (Spain)

^d SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^e BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

CRP; Diabetes; Genome wide scan; Insulin resistance; Linkage

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BODY MASS; CHROMOSOME 5P; CONTROLLED STUDY; FEMALE; GENE IDENTIFICATION; GENE LOCUS; GENETIC LINKAGE; GENETIC REGULATION; GENOME ANALYSIS; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL;

ADULT; ANALYSIS OF VARIANCE; C-REACTIVE PROTEIN; CHROMOSOMES, HUMAN, PAIR 5; DIABETES MELLITUS, TYPE 2; FAMILY HEALTH; FEMALE; GENOME, HUMAN; HUMANS; LINKAGE (GENETICS); LOD SCORE; MALE; MIDDLE AGED;

EID: 38349187317     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.01.036     Document Type: Article

References (36)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Ridker P.M. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 148 Suppl 1 (2004) S19-S26
3. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., and Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286 (2001) 327-334
4. Florez H., Castillo-Florez S., Mendez A., et al. C-reactive protein is elevated in obese patients with the metabolic syndrome. Diab Res Clin Pract 71 (2006) 92-100
5. Bruun J.M., Helge J.W., Richelsen B., and Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab 290 (2006) E961-E967
6. Pankow J.S., Folsom A.R., Cushman M., et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 (2001) 681-689
7. Austin M.A., Zhang C., Humphries S.E., et al. Heritability of C-reactive protein and association with apolipoprotein E genotypes in Japanese Americans. Ann Hum Genet 68 (2004) 179-188
8. Dupuis J., Larson M.G., Vasan R.S., et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q. Atherosclerosis 182 (2005) 307-314
9. Retterstol L., Eikvar L., and Berg K. A twin study of C-reactive protein compared to other risk factors for coronary heart disease. Atherosclerosis 169 (2003) 279-282
10. Suk H.J., Ridker P.M., Cook N.R., and Zee R.Y. Relation of polymorphism within the C-reactive protein gene and plasma CRP levels. Atherosclerosis 178 (2005) 139-145
11. Kovacs A., Green F., Hansson L.O., et al. A novel common single nucleotide polymorphism in the promoter region of the C-reactive protein gene associated with the plasma concentration of C-reactive protein. Atherosclerosis 178 (2005) 193-198
12. Miller D.T., Zee R.Y., Suk D.J., et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69 (2005) 623-638
13. Carlson C.S., Aldred S.F., Lee P.K., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77 (2005) 64-77
14. Kathiresan S., Larson M.G., Vasan R.S., et al. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113 (2006) 1415-1423
15. Judson R., Brain C., Dain B., et al. New and confirmatory evidence of an association between APOE genotype and baseline C-reactive protein in dyslipidemic individuals. Atherosclerosis 177 (2004) 345-351
16. Ferrari S.L., Ahn-Luong L., Garnero P., Humphries S.E., and Greenspan S.L. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 88 (2003) 255-259
17. Berger P., McConnell J.P., Nunn M., et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine 17 (2002) 171-174
18. Gander M.L., Fischer J.E., Maly F.E., and von Kanel R. Effect of the G-308A polymorphism of the tumor necrosis factor (TNF)-alpha gene promoter site on plasma levels of TNF-alpha and C-reactive protein in smokers: a cross-sectional study. BMC Cardiovasc Disord 4 (2004) 17
19. Zhang Y.Y., Gottardo L., Mlynarski W., et al. Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis 191 (2007) 121-127
20. Krolewski A.S., Poznik G.D., Placha G., et al. A genome-wide linkage scan for genes controlling variation in urinary albumin excretion in type II diabetes. Kidney Int 69 (2006) 129-136
21. Weber J.L., and Broman K.W. Genotyping for human whole-genome scans: past, present, and future. Adv Genet 42 (2001) 77-96
22. McPeek M.S., and Sun L. Statistical tests for detection of misspecified relationships by use of genome-screen data. Am J Hum Genet 66 (2000) 1076-1094
23. O'Connell J.R., and Weeks D.E. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. Am J Hum Genet 63 (1998) 259-266
24. Boehnke M. Allele frequency estimation from data on relatives. Am J Hum Genet 48 (1991) 22-25
25. Almasy L., and Blangero J. Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet 62 (1998) 1198-1211
26. Pratt S.C., Daly M.J., and Kruglyak L. Exact multipoint quantitative-trait linkage analysis in pedigrees by variance components. Am J Hum Genet 66 (2000) 1153-1157
27. Amos C.I. Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet 54 (1994) 535-543
28. Feingold E., Brown P.O., and Siegmund D. Gaussian models for genetic linkage analysis using complete high-resolution maps of identity by descent. Am J Hum Genet 53 (1993) 234-251
29. Greenfield J.R., Samaras K., Jenkins A.B., et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation 109 (2004) 3022-3028
30. Gabay C., and Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999) 448-454
31. Pickup J.C., and Crook M.A. Is type II diabetes mellitus a disease of the innate immune system?. Diabetologia 41 (1998) 1241-1248
32. Hotamisligil G.S. Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord 27 Suppl 3 (2003) S53-S55
33. Cai D., Yuan M., Frantz D.F., et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med 11 (2005) 183-190
34. Lee J., Ho W.H., Maruoka M., et al. IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1. J Biol Chem 276 (2001) 1660-1664
35. Lakka T.A., Rankinen T., Rice T., et al. A Quantitative Trait Locus on Chromosome 20q13 for Plasma Levels of C-Reactive Protein in Healthy Whites: The HERITAGE Family Study. Physiol Genomics 27 (2006) 103-107
36. Hu P., Greendale G.A., Palla S.L., et al. The effects of hormone therapy on the markers of inflammation and endothelial function and plasma matrix metalloproteinase-9 level in postmenopausal women: The postmenopausal estrogen progestin intervention (PEPI) trial. Atherosclerosis 185 (2005) 347-352